Chrostek L, Cylwik B, Panasiuk A, Brodowska-Adamusiak D, Gruszewska E

Idioma: Ingles.
Referencias bibliográficas: 16
Paginas: 150-154
Archivo PDF: 74.33 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Schauer R, Kelm S, Reuter G, Roggentin P, Shaw L. Biochemistry and role of sialic acid. In: Rosenberg A (ed.). Biology of the sialic acids. New York: Plenum Press; 1995, p. 7-47.

2. Millar JS, Anber V, Shepherd J, Packard CJ. Sialic acid-containing components of lipoproteins influence lipoproteinproteoglycan interactions. Atherosclerosis 1999; 145: 253-60.

3. Marmillot P, Rao MN, Liu QH, Lakshman MR. Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver estrified cholesterol to the liver. Metabolism 1999; 48: 1184-92.

4. Sillanaukee P, Ponnio M, Jaaskelainen IP. Occurrence of sialic acid in healthy humans and different disorders. Eur J Clin Invest 1999; 29: 413-25.

5. Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Alteration of protein glycosylation in liver diseases. J Hepatol 2009; 50: 592-603.

6. Senn JH, Sellin S, Fitzke E, Stehle T, Häussinger D, Wieland H, Gerok W. Biosynthesis and excretion of gangliosides by isolated perfused rat liver. Eur J Biochem 1992; 205: 809-14.

7. Senn HJ, Orth M, Fitzke E, Wieland H, Gerok W. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur J Biochem 1989; 181: 657-62.

8. Senn HJ, Orth M, Fitzke E, Schölmerich J, Köster W, Wieland H, Gerok W. Altered concentrations, pattern and distribution in lipoproteins of serum gangliosides in liver diseases of different etiologies. J Hepatol 1990; 11: 290-6.

9. Katopodis N, Stock CC. Improved method to determine lipid- bound sialic acid in plasma or serum. Res Commun Chem Pathol Pharmacol 1980; 30: 171-80.

10. Schutter EM, Visser JJ, van Kamp GJ, Mensdorff-Pouilly S, van Dijk W, Hilgers J, et al. The utility of lipid-associated sialic acid (LASA or LSA) as a marker for malignancy. A review of the literature. Tumor Biol 1992; 13: 121-32.

11. Arif S, Haq N, Hanif R, Khan AS, Rehman J, Mufti TA. Variations of serum sialic acid level in liver cirrhosis. J Ayub Med Coll Abbottabad 2005; 17: 54-7.

12. Matsuzaki S, Itakura M, Iwamura K, Kamiguchi H. Serum sialic acid levels in liver cirrhosis and liver cancer. Jpn J Gastro-Enterol 1981; 78: 2395-401.

13. Seidel D. Lipoproteins in liver disease. J Clin Chem Clin Biochem 1987; 25: 541-51.

14. Dabelic S, Flögel M, Maravic G, Lauc G. Stress causes tissue- specific changes in the sialyltransferase activity. Z Naturforsch C 2004; 59: 276-80.

15. Stefenelli N, Klotz H, Engel A, Bauer P. Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. J Cancer Res Clin Oncol 1985; 109: 55-9.

16. Cylwik B, Chrostek L, Panasiuk A, Szmitkowski M. Serum total and free sialic acid in patients with chronic liver disease. Clin Chem Lab Med 2010; 48: 137-9.